Skip to content
Disclosery

Paradigm Biocapital Advisors LP: APGE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on APGE, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 1,576,385 APGE shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,576,385 shares
    Change vs previous 13F +228,142 shares

    3.92% of the 13F portfolio, value $209,233,581.

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,348,243 shares
    Change vs previous 13F +225,000 shares

    2.32% of the 13F portfolio, value $113,481,613.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,123,243 shares
    Change vs previous 13F -398,514 shares

    2.27% of the 13F portfolio, value $84,782,382.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,521,757 shares
    Change vs previous 13F +563,127 shares

    1.79% of the 13F portfolio, value $60,459,406.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 958,630 shares
    Change vs previous 13F -3,077 shares

    1.78% of the 13F portfolio, value $41,633,301.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 961,707 shares
    Change vs previous 13F -322,059 shares

    1.65% of the 13F portfolio, value $35,929,374.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,283,766 shares
    Change vs previous 13F +581,949 shares

    2.02% of the 13F portfolio, value $58,154,600.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 701,817 shares
    Change vs previous 13F not available

    1.44% of the 13F portfolio, value $41,224,731.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).